TY - JOUR T1 - Activation of NF-kB pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells JF - Molecular Pharmacology JO - Mol Pharmacol DO - 10.1124/mol.108.045286 AU - Chiara Riganti AU - Sophie Doublier AU - Costanzo Costamagna AU - Elisabetta Aldieri AU - Gianpiero Pescarmona AU - Dario Ghigo AU - Amalia Bosia Y1 - 2008/05/07 UR - http://molpharm.aspetjournals.org/content/early/2008/05/07/mol.108.045286.abstract N2 - 300 Multiple ChoicesThis is a pdf-only article and there is no markup to show you.full-text.pdf ER -